EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders

Aarish Manzar iD, Aleksandar Sic iD, Crystal Banh, Nebojsa Nick Knezevic iD

Cells · 20.07.2025 · 14 (14) · 1114

DOI: 10.3390/cells14141114 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 20.07.2025. Verfasst von Aarish Manzar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Mental Disorders, Endocrine System Diseases, Pain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Calcium channel blockers (CCBs), originally developed for cardiovascular indications, have gained attention for their therapeutic potential in neuropsychiatric, endocrine, and pain-related disorders. In neuropsychiatry, nimodipine and isradipine, both L-type CCBs, show mood-stabilizing and neuroprotective effects, with possible benefits in depression, bipolar disorder, and schizophrenia. In endocrinology, verapamil, a non-dihydropyridine L-type blocker, has been associated with the preservation of pancreatic β-cell function and reduced insulin dependence in diabetes. CCBs may also aid in managing primary aldosteronism and pheochromocytoma, particularly in patients with calcium signaling mutations. In pain medicine, α2δ ligands and selective blockers of N-type and T-type channels demonstrate efficacy in neuropathic and inflammatory pain. However, their broader use is limited by challenges in central nervous system (CNS) penetration, off-target effects, and heterogeneous trial outcomes. Future research should focus on pharmacogenetic stratification, novel delivery platforms, and combination strategies to optimize repurposing of CCBs across disciplines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channel BlockersMental DisordersEndocrine System DiseasesPainNervous System DiseasesHumansAnimals

Stichwörter der Autor:innen

L-type voltage-gated calcium channelscalcium signaling dysregulationcentral nervous system pharmacotherapydrug repurposingmood stabilizationneuroinflammationpharmacovigilance

Substanzen

Calcium Channel Blockers

Autor:innen und Institutionen

  • Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, IL 60657, USA.
  • Department of Internal Medicine, Ziauddin Medical College, Karachi 75500, Pakistan.
  • Department of Anesthesiology, University of Illinois, Chicago, IL 60612, USA.
  • Department of Surgery, University of Illinois, Chicago, IL 60612, USA.

ORCID-Profile: Aarish Manzar, Aleksandar Sic, Nebojsa Nick Knezevic

Zitieren

APA

Manzar, A., Sic, A., Banh, C., & Knezevic, N. N. (2025). Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders. Cells, 14(14), 1114. https://doi.org/10.3390/cells14141114

Vancouver

Manzar A, Sic A, Banh C, Knezevic NN. Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders. Cells. 2025;14(14):1114. doi:10.3390/cells14141114

BibTeX
@article{Manzar2025,
  author = {Manzar, Aarish and Sic, Aleksandar and Banh, Crystal and Knezevic, Nebojsa Nick},
  title = {Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {14},
  pages = {1114},
  doi = {10.3390/cells14141114}
}
Kostenlos starten →